{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:16:00Z","timestamp":1787890560436,"version":"build-2784847793"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the National Key Research and Development Program of China The registry study of rare disease in children","award":["2016YFC0901505"],"award-info":[{"award-number":["2016YFC0901505"]}]},{"name":"the National Nature Science Foundation","award":["81400685"],"award-info":[{"award-number":["81400685"]}]},{"name":"Beijing key laboratory of molecular diagnosis and study on pediatric genetic diseases","award":["BZ0317"],"award-info":[{"award-number":["BZ0317"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00467-017-3784-3","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T08:55:04Z","timestamp":1504256104000},"page":"1309-1316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Renal, auricular, and ocular outcomes of Alport syndrome and their current management"],"prefix":"10.1007","volume":"33","author":[{"given":"Yanqin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,1]]},"reference":[{"key":"3784_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1681\/ASN.V12197","volume":"12","author":"L Heidet","year":"2001","unstructured":"Heidet L, Arrondel C, Forestier L, Cohen-Solal L, Mollet G, Gutierrez B, Stavrou C, Gubler MC, Antignac C (2001) Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J Am Soc Nephrol 12:97\u2013106","journal-title":"J Am Soc Nephrol"},{"key":"3784_CR2","first-page":"1221","volume":"59","author":"B Knebelmann","year":"1996","unstructured":"Knebelmann B, Breillat C, Forestier L, Arrondel C, Jacassier D, Giatras I, Drouot L, Desch\u00eanes G, Gr\u00fcnfeld JP, Broyer M, Gubler MC, Antignac C (1996) Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet 59:1221\u20131232","journal-title":"Am J Hum Genet"},{"key":"3784_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/humu.9349","volume":"26","author":"M Nagel","year":"2005","unstructured":"Nagel M, Nagorka S, Gross O (2005) Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. Hum Mutat 26:60","journal-title":"Hum Mutat"},{"key":"3784_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrneph.2012.259","volume":"9","author":"J Kruegel","year":"2013","unstructured":"Kruegel J, Rubel D, Gross O (2013) Alport syndrome\u2014insights from basic and clinical research. Nat Rev Nephrol 9:170\u2013178","journal-title":"Nat Rev Nephrol"},{"key":"3784_CR5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"JP Jais","year":"2000","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schr\u00f6der C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-linked Alport syndrome: natural history in 195 families and genotype\u2013phenotype correlations in males. J Am Soc Nephrol 11:649\u2013657","journal-title":"J Am Soc Nephrol"},{"key":"3784_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jmoldx.2012.06.005","volume":"14","author":"F Wang","year":"2012","unstructured":"Wang F, Zhao D, Ding J, Zhang H, Zhang Y, Yu L, Xiao H, Yao Y, Zhong X, Wang S (2012) Skin biopsy is a practical approach for the clinical diagnosis and molecular genetic analysis of X-linked Alport's syndrome. J Mol Diagn 14:586\u2013593","journal-title":"J Mol Diagn"},{"key":"3784_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00467-013-2643-0","volume":"29","author":"Y Wang","year":"2014","unstructured":"Wang Y, Sivakumar V, Mohammad M, Colville D, Storey H, Flinter F, Dagher H, Savige J (2014) Clinical and genetic features in autosomal recessive and X-linked Alport syndrome. Pediatr Nephrol 29:391\u2013396","journal-title":"Pediatr Nephrol"},{"key":"3784_CR8","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1002\/ajmg.a.35528","volume":"158A","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Wang F, Ding J, Zhang H, Zhao D, Yu L, Xiao H, Yao Y, Zhong X, Wang S (2012) Genotype-phenotype correlations in 17 Chinese patients with autosomal recessive Alport syndrome. Am J Med Genet A 158A:2188\u20132193","journal-title":"Am J Med Genet A"},{"key":"3784_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejmg.2014.10.003","volume":"58","author":"C Rosado","year":"2015","unstructured":"Rosado C, Bueno E, Fraile P, Garc\u00eda-Cosmes P, Gonz\u00e1lez-Sarmiento R (2015) A new mutation in the COL4A3 gene responsible for\u2002autosomal\u2002dominant\u2002Alport syndrome, which only generates hearing loss in some carriers. Eur J Med Genet 58:35\u201338","journal-title":"Eur J Med Genet"},{"key":"3784_CR10","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2215\/CJN.01000116","volume":"11","author":"N Kamiyoshi","year":"2016","unstructured":"Kamiyoshi N, Nozu K, Fu XJ, Morisada N, Nozu Y, Ye MJ, Imafuku A, Miura K, Yamamura T, Minamikawa S, Shono A, Ninchoji T, Morioka I, Nakanishi K, Yoshikawa N, Kaito H, Iijima K (2016) Genetic, clinical, and pathologic backgrounds of patients with autosomal dominant Alport syndrome. Clin J Am Soc Nephrol 11:1441\u20131449","journal-title":"Clin J Am Soc Nephrol"},{"key":"3784_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1681\/ASN.2012020148","volume":"24","author":"J Savige","year":"2013","unstructured":"Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F (2013) Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol 24:364\u2013375","journal-title":"J Am Soc Nephrol"},{"key":"3784_CR12","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","volume":"14","author":"JP Jais","year":"2003","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Dahan K, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schr\u00f6der C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \"European Community Alport syndrome concerted action\" study. J Am Soc Nephrol 14:2603\u20132610","journal-title":"J Am Soc Nephrol"},{"key":"3784_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","volume":"52","author":"MA Mencarelli","year":"2015","unstructured":"Mencarelli MA, Heidet L, Storey H, van Geel M, Knebelmann B, Fallerini C, Miglietti N, Antonucci MF, Cetta F, Sayer JA, van den Wijngaard A, Yau S, Mari F, Bruttini M, Ariani F, Dahan K, Smeets B, Antignac C, Flinter F, Renieri A (2015) Evidence of digenic inheritance in Alport syndrome. J Med Genet 52:163\u2013174","journal-title":"J Med Genet"},{"key":"3784_CR14","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ki.2011.407","volume":"81","author":"O Gross","year":"2012","unstructured":"Gross O, Licht C, Anders HJ, Hoppe B, Beck B, T\u00f6nshoff B, H\u00f6cker B, Wygoda S, Ehrich JH, Pape L, Konrad M, Rascher W, D\u00f6tsch J, M\u00fcller-Wiefel DE, Hoyer P, Study Group Members of the Gesellschaft f\u00fcr P\u00e4diatrische Nephrologie, Knebelmann B, Pirson Y, Grunfeld JP, Niaudet P, Cochat P, Heidet L, Lebbah S, Torra R, Friede T, Lange K, M\u00fcller GA, Weber M (2012) Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 81:494\u2013501","journal-title":"Kidney Int"},{"key":"3784_CR15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/ki.2011.452","volume":"81","author":"J Temme","year":"2012","unstructured":"Temme J, Peters F, Lange K, Pirson Y, Heidet L, Torra R, Grunfeld JP, Weber M, Licht C, M\u00fcller GA, Gross O (2012) Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations. Kidney Int 81:779\u2013783","journal-title":"Kidney Int"},{"key":"3784_CR16","doi-asserted-by":"crossref","unstructured":"Webb NJ, Lam C, Shahinfar S, Strehlau J, Wells TG, Gleim GW, Le Bailly De Tilleghem C (2011) Efficacy and safety of losartan in children with Alport syndrome\u2013results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial. Nephrol Dial Transplant 26:2521\u20132526","DOI":"10.1093\/ndt\/gfq797"},{"key":"3784_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00467-012-2372-9","volume":"28","author":"NJ Webb","year":"2013","unstructured":"Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C (2013) Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome. Pediatr Nephrol 28:737\u2013743","journal-title":"Pediatr Nephrol"},{"key":"3784_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00467-015-3184-5","volume":"31","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Wang F, Ding J, Zhang H, Liu X, Wang S, Xiao H, Yao Y, Liu J, Zhong X, Guan N, Su B, Wu G, Yu L (2016) Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome. Pediatr Nephrol 31:67\u201372","journal-title":"Pediatr Nephrol"},{"key":"3784_CR19","doi-asserted-by":"publisher","first-page":"436046","DOI":"10.5402\/2012\/436046","volume":"2012","author":"O Gross","year":"2012","unstructured":"Gross O, Friede T, Hilgers R, G\u00f6rlitz A, Gav\u00e9nis K, Ahmed R, D\u00fcrr U (2012) Safety and efficacy of the ACE-inhibitor ramipril in Alport syndrome: the double-blind, randomized, placebo-controlled, multicenter phase III EARLY PRO-TECT Alport trial in pediatric patients. ISRN Pediatr 2012:436046","journal-title":"ISRN Pediatr"},{"key":"3784_CR20","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s00467-010-1484-3","volume":"25","author":"L Massella","year":"2010","unstructured":"Massella L, Muda AO, Legato A, Di Zazzo G, Giannakakis K, Emma F (2010) Cyclosporine a treatment in patients with Alport syndrome: a single-center experience. Pediatr Nephrol 25:1269\u20131275","journal-title":"Pediatr Nephrol"},{"key":"3784_CR21","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1046\/j.1523-1755.1999.0550031051.x","volume":"55","author":"L Call\u00eds","year":"1999","unstructured":"Call\u00eds L, Vila A, Carrera M, Nieto J (1999) Long-term effects of cyclosporine A in Alport's syndrome. Kidney Int 55:1051\u20131056","journal-title":"Kidney Int"},{"key":"3784_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s10157-013-0836-2","volume":"18","author":"K Sugimoto","year":"2014","unstructured":"Sugimoto K, Fujita S, Miyazawa T, Nishi H, Enya T, Izu A, Wada N, Sakata N, Okada M, Takemura T (2014) Cyclosporin A may cause injury to undifferentiated glomeruli persisting in patients with Alport syndrome. Clin Exp Nephrol 18:492\u2013498","journal-title":"Clin Exp Nephrol"},{"key":"3784_CR23","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.2215\/CJN.02190312","volume":"7","author":"J Temme","year":"2012","unstructured":"Temme J, Kramer A, Jager KJ, Lange K, Peters F, M\u00fcller GA, Kramar R, Heaf JG, Finne P, Palsson R, Reis\u00e6ter AV, Hoitsma AJ, Metcalfe W, Postorino M, Zurriaga O, Santos JP, Ravani P, Jarraya F, Verrina E, Dekker FW, Gross O (2012) Outcomes of male patients with Alport syndrome undergoing renal replacement therapy. Clin J Am Soc Nephrol 7:1969\u20131976","journal-title":"Clin J Am Soc Nephrol"},{"key":"3784_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/0886022X.2016.1262266","volume":"39","author":"YP Kelly","year":"2017","unstructured":"Kelly YP, Patil A, Wallis L, Murray S, Kant S, Kaballo MA, Casserly L, Doyle B, Dorman A, O'Kelly P, Conlon PJ (2017) Outcomes of kidney transplantation in Alport syndrome compared with other forms of renal disease. Ren Fail 39:290\u2013293","journal-title":"Ren Fail"},{"key":"3784_CR25","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.transproceed.2015.04.025","volume":"47","author":"VT Yilmaz","year":"2015","unstructured":"Yilmaz VT, Dinckan A, Yilmaz F, Suleymanlar G, Kocak H (2015) Outcomes of renal transplantation in patients with Alport syndrome. Transplant Proc 47:1377\u20131381","journal-title":"Transplant Proc"},{"key":"3784_CR26","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1093\/ndt\/gfu254","volume":"29","author":"A Mallett","year":"2014","unstructured":"Mallett A, Tang W, Clayton PA, Stevenson S, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Campbell SB, Johnson DW (2014) End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases. Nephrol Dial Transplant 29:2277\u20132286","journal-title":"Nephrol Dial Transplant"},{"key":"3784_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.transproceed.2011.11.035","volume":"44","author":"MR Gumber","year":"2012","unstructured":"Gumber MR, Kute VB, Goplani KR, Vanikar AV, Shah PR, Patel HV, Trivedi HL (2012) Outcome of renal transplantation in Alport's syndrome: a single-center experience. Transplant Proc 44:261\u2013263","journal-title":"Transplant Proc"},{"key":"3784_CR28","doi-asserted-by":"crossref","unstructured":"De Sandes-Freitas TV, Holanda-Cavalcanti A, Mastroianni-Kirsztajn G, Franco MF, Medina-Pestana JO (2011) Late presentation of Alport posttransplantation anti-glomerular basement membrane disease. Transplant Proc 43:4000\u20134001","DOI":"10.1016\/j.transproceed.2011.08.082"},{"key":"3784_CR29","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1093\/ndt\/gfn635","volume":"24","author":"O Gross","year":"2009","unstructured":"Gross O, Weber M, Fries JW, M\u00fcller GA (2009) Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome. Nephrol Dial Transplant 24:1626\u20131630","journal-title":"Nephrol Dial Transplant"},{"key":"3784_CR30","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/ndt\/gfn779","volume":"24","author":"CE Kashtan","year":"2009","unstructured":"Kashtan CE (2009) Women with Alport syndrome: risks and rewards of kidney donation. Nephrol Dial Transplant 24:1369\u20131370","journal-title":"Nephrol Dial Transplant"},{"key":"3784_CR31","first-page":"1157","volume":"58","author":"DF Barker","year":"1996","unstructured":"Barker DF, Pruchno CJ, Jiang X, Atkin CL, Stone EM, Denison JC, Fain PR, Gregory MC (1996) A mutation causing Alport syndrome with tardive hearing loss is common in the western United States. Am J Hum Genet 58:1157\u20131165","journal-title":"Am J Hum Genet"},{"key":"3784_CR32","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1808-8694(15)30140-3","volume":"74","author":"FR Alves","year":"2008","unstructured":"Alves FR, Ribeiro Fde A (2008) Clinical data and hearing of individuals with Alport syndrome. Braz J Otorhinolaryngol 74:807\u2013814","journal-title":"Braz J Otorhinolaryngol"},{"key":"3784_CR33","first-page":"902","volume":"49","author":"L Chen","year":"2014","unstructured":"Chen L, Xue J, Zhang Y, Wang F, Chen S, Duan J, Liu Y, Ding J (2014) Analysis of the clinical audiological characteristics in 92 Chinese Alport syndrome cases. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 49:902\u2013907","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"3784_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/13816819709041431","volume":"18","author":"DJ Colville","year":"1997","unstructured":"Colville DJ, Savige J (1997) Alport syndrome. A review of the ocular manifestations. Ophthalmic Genet 18:161\u2013173","journal-title":"Ophthalmic Genet"},{"key":"3784_CR35","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2215\/CJN.10581014","volume":"10","author":"J Savige","year":"2015","unstructured":"Savige J, Sheth S, Leys A, Nicholson A, Mack HG, Colville D (2015) Ocular features in Alport syndrome: pathogenesis and clinical significance. Clin J Am Soc Nephrol 10:703\u2013709","journal-title":"Clin J Am Soc Nephrol"},{"key":"3784_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/ndt\/gfl607","volume":"22","author":"EA Shaw","year":"2007","unstructured":"Shaw EA, Colville D, Wang YY, Zhang KW, Dagher H, Fassett R, Guymer R, Savige J (2007) Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome. Nephrol Dial Transplant 22:104\u2013108","journal-title":"Nephrol Dial Transplant"},{"key":"3784_CR37","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1136\/bjo.2009.158089","volume":"93","author":"AA Fawzi","year":"2009","unstructured":"Fawzi AA, Lee NG, Eliott D, Song J, Stewart JM (2009) Retinal findings in patients with Alport syndrome: expanding the clinical spectrum. Br J Ophthalmol 93:1606\u20131611","journal-title":"Br J Ophthalmol"},{"key":"3784_CR38","first-page":"553","volume":"70","author":"HI Cheong","year":"1994","unstructured":"Cheong HI, Kashtan CE, Kim Y, Kleppel MM, Michael AF (1994) Immunohistologic studies of type IV collagen in anterior lens capsules of patients with Alport syndrome. Lab Investig 70:553\u2013557","journal-title":"Lab Investig"},{"key":"3784_CR39","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1001\/archopht.121.6.846","volume":"121","author":"S Ohkubo","year":"2003","unstructured":"Ohkubo S, Takeda H, Higashide T, Ito M, Sakurai M, Shirao Y, Yanagida T, Oda Y, Sado Y (2003) Immunohistochemical and molecular genetic evidence for type IV collagen alpha5 chain abnormality in the anterior lenticonus associated with Alport syndrome. Arch Ophthalmol 121:846\u2013850","journal-title":"Arch Ophthalmol"},{"key":"3784_CR40","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1177\/147323000803600634","volume":"36","author":"YB Liu","year":"2008","unstructured":"Liu YB, Tan SJ, Sun ZY, Li X, Huang BY, Hu QM (2008) Clear lens phacoemulsification with continuous curvilinear capsulorhexis and foldable intraocular lens implantation for the treatment of a patient with bilateral anterior lenticonus due to Alport syndrome. J Int Med Res 36:1440\u20131444","journal-title":"J Int Med Res"},{"key":"3784_CR41","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/ICO.0b013e31818f9706","volume":"28","author":"KS Bower","year":"2009","unstructured":"Bower KS, Edwards JD, Wagner ME, Ward TP, Hidayat A (2009) Novel corneal phenotype in a patient with Alport syndrome. Cornea 28:599\u2013606","journal-title":"Cornea"},{"key":"3784_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4103\/0301-4738.16691","volume":"53","author":"V Vedantham","year":"2005","unstructured":"Vedantham V, Rajagopal J, Ratnagiri PK (2005) Bilateral simultaneous anterior and posterior lenticonus in Alport's syndrome. Indian J Ophthalmol 53:212\u2013213","journal-title":"Indian J Ophthalmol"},{"key":"3784_CR43","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/ki.1997.321","volume":"52","author":"C Rhys","year":"1997","unstructured":"Rhys C, Snyers B, Pirson Y (1997) Recurrent corneal erosion associated with Alport's syndrome. Rapid communication. Kidney Int 52:208\u2013211","journal-title":"Kidney Int"},{"key":"3784_CR44","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s00417-002-0471-1","volume":"240","author":"S Saika","year":"2002","unstructured":"Saika S, Hayashi Y, Miyamoto T, Yoshitomi T, Ohnishi Y (2002) Multiple retinal holes in the macular region: a case report. Graefes Arch Clin Exp Ophthalmol 240:578\u2013579","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3784_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3341\/kjo.2005.19.1.84","volume":"19","author":"J Choi","year":"2005","unstructured":"Choi J, Ks N, Bae S, Roh G (2005) Anterior lens capsule abnormalities in Alport syndrome. Korean J Ophthalmol 19:84\u201389","journal-title":"Korean J Ophthalmol"},{"key":"3784_CR46","first-page":"2205","volume":"18","author":"C Zhao","year":"2012","unstructured":"Zhao C, Wang F, Zhang Y, Wen Y, Su Y, Zhang C, Sui R, Xu F, Ding J, Dong F (2012) A novel splice site mutation in the COL4A5 gene in a Chinese female patient with rare ocular abnormalities. Mol Vis 18:2205\u20132212","journal-title":"Mol Vis"},{"key":"3784_CR47","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1634\/stemcells.2006-0201","volume":"24","author":"EI Prodromidi","year":"2006","unstructured":"Prodromidi EI, Poulsom R, Jeffery R, Roufosse CA, Pollard PJ, Pusey CD, Cook HT (2006) Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 24:2448\u20132455","journal-title":"Stem Cells"},{"key":"3784_CR48","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1681\/ASN.2009010123","volume":"20","author":"V LeBleu","year":"2009","unstructured":"LeBleu V, Sugimoto H, Mundel TM, Gerami-Naini B, Finan E, Miller CA, Gattone VH 2nd, Lu L, Shield CF 3rd, Folkman J, Kalluri R (2009) Stem cell therapies benefit Alport syndrome. J Am Soc Nephrol 20:2359\u20132370","journal-title":"J Am Soc Nephrol"},{"key":"3784_CR49","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1681\/ASN.2011030243","volume":"23","author":"S Sedrakyan","year":"2012","unstructured":"Sedrakyan S, Da Sacco S, Milanesi A, Shiri L, Petrosyan A, Varimezova R, Warburton D, Lemley KV, De Filippo RE, Perin L (2012) Injection of amniotic fluid stem cells delays progression of renal fibrosis. J Am Soc Nephrol 23:661\u2013673","journal-title":"J Am Soc Nephrol"},{"key":"3784_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/sj.ki.5001521","volume":"70","author":"V Ninichuk","year":"2006","unstructured":"Ninichuk V, Gross O, Segerer S, Hoffmann R, Radomska E, Buchstaller A, Huss R, Akis N, Schl\u00f6ndorff D, Anders HJ (2006) Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 70:121\u2013129","journal-title":"Kidney Int"},{"key":"3784_CR51","first-page":"21","volume":"3","author":"P Heikkila","year":"1996","unstructured":"Heikkila P, Parpala T, Lukkarinen O, Weber M, Tryggvason K (1996) Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system\u2014first steps towards gene therapy of Alport syndrome. Gene Ther 3:21\u201327","journal-title":"Gene Ther"},{"key":"3784_CR52","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/sj.gt.3301342","volume":"8","author":"P Heikkil\u00e4","year":"2001","unstructured":"Heikkil\u00e4 P, Tibell A, Morita T, Chen Y, Wu G, Sado Y, Ninomiya Y, Pettersson E, Tryggvason K (2001) Adenovirus-mediated transfer of type IV collagen alpha5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane. Gene Ther 8:882\u2013890","journal-title":"Gene Ther"},{"key":"3784_CR53","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0002-9440(10)63883-7","volume":"162","author":"SJ Harvey","year":"2003","unstructured":"Harvey SJ, Zheng K, Jefferson B, Moak P, Sado Y, Naito I, Ninomiya Y, Jacobs R, Thorner PS (2003) Transfer of the alpha 5(IV) collagen chain gene to smooth muscle restores in vivo expression of the alpha 6(IV) collagen chain in a canine model of Alport syndrome. Am J Pathol 162:873\u2013885","journal-title":"Am J Pathol"},{"key":"3784_CR54","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1681\/ASN.2013070798","volume":"25","author":"X Lin","year":"2014","unstructured":"Lin X, Suh JH, Go G, Miner JH (2014) Feasibility of repairing glomerular basement membrane defects in Alport syndrome. J Am Soc Nephrol 25:687\u2013692","journal-title":"J Am Soc Nephrol"},{"key":"3784_CR55","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.matbio.2010.03.002","volume":"29","author":"O Gross","year":"2010","unstructured":"Gross O, Girgert R, Beirowski B, Kretzler M, Kang HG, Kruegel J, Miosge N, Busse AC, Segerer S, Vogel WF, M\u00fcller GA, Weber M (2010) Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease. Matrix Biol 29:346\u2013356","journal-title":"Matrix Biol"},{"key":"3784_CR56","doi-asserted-by":"crossref","unstructured":"Omachi K, Miyakita R, Fukuda R, Kai Y, Suico MA, Yokota T, Kamura M, Shuto T, Kai H (2017) Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model. Clin Exp Nephrol. https:\/\/doi.org\/10.1007\/s10157-017-1386-9","DOI":"10.1007\/s10157-017-1386-9"},{"key":"3784_CR57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1755-1536-3-19","volume":"3","author":"R Girgert","year":"2010","unstructured":"Girgert R, Martin M, Kruegel J, Miosge N, Temme J, Eckes B, M\u00fcller GA, Gross O (2010) Integrin \u03b12-deficient mice provide insights into specific functions of collagen receptors in the kidney. Fibrogenesis Tissue Repair 3:19","journal-title":"Fibrogenesis Tissue Repair"},{"key":"3784_CR58","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.kint.2016.02.018","volume":"90","author":"B Dufek","year":"2016","unstructured":"Dufek B, Meehan DT, Delimont D, Cheung L, Gratton MA, Phillips G, Song W, Liu S, Cosgrove D (2016) Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease. Kidney Int 90:300\u2013310","journal-title":"Kidney Int"},{"key":"3784_CR59","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1172\/JCI75852","volume":"125","author":"IG Gomez","year":"2015","unstructured":"Gomez IG, MacKenna DA, Johnson BG, Kaimal V, Roach AM, Ren S, Nakagawa N, Xin C, Newitt R, Pandya S, Xia TH, Liu X, Borza DB, Grafals M, Shankland SJ, Himmelfarb J, Portilla D, Liu S, Chau BN, Duffield JS (2015) Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways. J Clin Invest 125:141\u2013156","journal-title":"J Clin Invest"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-017-3784-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3784-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3784-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T02:02:24Z","timestamp":1659405744000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-017-3784-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["3784"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3784-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,1]]},"assertion":[{"value":"6 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}